Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "Phase 1b/2 CARTITUDE-1 Study Final Results - Ciltacabtagene Autoleucel in Heavily Pretreated Patients With R/R MM"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Yi Lin
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Yi Lin
134 views
July 14, 2023
Login to view comments.
Click here to Login
Hematology